Saudi Electronic University, Department of Public Health, P. O. Box 93499, Riyadh 11673, Saudi Arabia.
J Infect Public Health. 2021 Jan;14(1):53-60. doi: 10.1016/j.jiph.2020.10.018. Epub 2020 Dec 9.
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China in December 2019 and is associated with high levels of morbidity and mortality. Various types of bacterial and fungal infections occur in patients with COVID-19 with some resistant to antimicrobials that are associated with significantly worse outcomes and deaths. Besides, antimicrobial-resistant (AMR) co-infections are responsible for clinically significant mortality in past pandemics. There is evidence to suggest that factors such as the proliferation of adulterated antimicrobials in some developing countries, international travels, issues with healthcare financing, use/misuse by humans, and in agricultural production and climate change are determinants of AMR at various levels of society. These complex interrelated determinants intersect with AMR in current and past pandemics and could amplify the potential of a future antimicrobial resistance pandemic. Therefore, global concerted interventions targeted at all levels of society to reduce the use/misuse of antimicrobials and disrupt these multifaceted, interrelated, and interdependent factors are urgently needed. This paper leverages prior research to describe complex major determinants of antimicrobial resistance and provides fresh insights into possible intervention strategies to tackle antimicrobial resistance including in the current and future pandemics.
由严重急性呼吸系统综合征冠状病毒 2 引起的 COVID-19 大流行于 2019 年 12 月在中国武汉首次报告,与高发病率和死亡率相关。COVID-19 患者会发生各种类型的细菌和真菌感染,其中一些对抗生素具有耐药性,这与明显更差的结果和死亡有关。此外,抗微生物药物耐药性(AMR)合并感染是过去大流行中导致临床显著死亡的原因。有证据表明,在一些发展中国家抗生素掺假的扩散、国际旅行、医疗保健融资问题、人类的使用/滥用以及农业生产和气候变化等因素是社会各层面 AMR 的决定因素。这些复杂的相互关联的决定因素与当前和过去大流行中的 AMR 相互交叉,并可能放大未来抗生素耐药性大流行的潜力。因此,迫切需要在社会各层面采取全球协同干预措施,以减少抗生素的使用/滥用,并打破这些多方面、相互关联和相互依存的因素。本文利用先前的研究来描述抗微生物药物耐药性的复杂主要决定因素,并提供对抗微生物药物耐药性的可能干预策略的新见解,包括在当前和未来的大流行中。